People wait in line to enter the mass vaccination site at M&T Bank Stadium and receive the Pfizer vaccine in Baltimore, on April 7, 2021. Photo: Diego M. Radzinschi/ALM

A San Diego biotech company has moved a step closer to claiming a share of Pfizer Inc. and BioNTech SE’s COVID-19 vaccine profits.